Pandemic of sensitivity to acrylate containing nail cosmetic among young Israeli women? Result of patch testing 2‐hydroxyethyl methacrylate in the European baseline series
Contact Dermatitis · 2024
DOI: 10.1111/cod.14683 ↗Kurz gefasst
Fachartikel in der Zeitschrift Contact Dermatitis, 2024. Verfasst von D Hilewitz und 8 weiteren Autor:innen. Beteiligte Einrichtung: Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. Hauptthemen laut MEDLINE: Dermatitis, Allergic Contact, Patch Tests, Methacrylates, Cosmetics. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
2‐Hydroxyethyl methacrylate (HEMA) was added into the European baseline series (EBS) in 2019. There is limited data regarding the frequency, relevance, and sources of exposure to HEMA.
Objectives
To investigate the frequency and clinical relevance of positive reactions to HEMA in the EBS in Israel, and explore sources of exposure.
Methods
Retrospective cohort study that included all patients who underwent patch testing with the EBS in a tertiary center in Israel between 2020 and 2023. Positive reactions to HEMA were stratified by sex, six age groups, and year of study. Sources of exposure to HEMA as well as occupational data were recorded.
Results
A total of 1671 consecutive patients underwent HEMA patch testing, with 135 (8.1%) showing positive reactions to HEMA (130 females, 5 males). The prevalence in women (11.0%) was significantly higher compared to men (1.0%) ( p < 0.001). Stratification by age and sex revealed the highest frequency of HEMA sensitivity of 16.7% among women younger than 30 years of age, with odds ratio of 2.3 (95%CI: 1.6–3.3, p < 0.001) compared to older women. There was an increase in frequency among women between the years 2022 and 2023 when compared to 2020–2021 (OR 1.7, 95%CI: 1.5–2.1, p < 0.01) attributable to COVID‐19 pandemic and social restrictions. Among men the frequency fluctuations over the study period and age categories were nonsignificant. 111 (84%) were judged to be of clinical relevance and nail cosmetics was responsible for 95% of them. Of 111 patients with relevant reaction (110 females, 1 males), 20 (18%) had occupational contact dermatitis (18 nails stylists, 2 dentists). Other culprit products included sanitary pads ( n = 4), medical adhesives ( n = 3), and paints ( n = 2).
Conclusion
We report the highest frequency of HEMA sensitivity to date of 8.1%, that was most common among young women and in vast majority of cases was attributable to nail cosmetics. Our findings reflect the popularity of nail cosmetics in Israel as well as the global trend of increasing sensitivity to (meth)acrylates.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
- Division of Dermatology, Rabin Medical Center, Petah Tikva, Israel.
ORCID-Profile: D Hilewitz
Zitieren
APA
Hilewitz, D., Trattner, A., Reiter, O., Uvaidov, V., Noyman, Y., Solomon Cohen, E., Hackett, A., Mimouni, D., & Snast, I. (2024). Pandemic of sensitivity to acrylate containing nail cosmetic among young Israeli women? Result of patch testing 2‐hydroxyethyl methacrylate in the European baseline series. Contact Dermatitis. https://doi.org/10.1111/cod.14683
Vancouver
Hilewitz D, Trattner A, Reiter O, Uvaidov V, Noyman Y, Solomon Cohen E, et al. Pandemic of sensitivity to acrylate containing nail cosmetic among young Israeli women? Result of patch testing 2‐hydroxyethyl methacrylate in the European baseline series. Contact Dermatitis. 2024. doi:10.1111/cod.14683
BibTeX
@article{Hilewitz2024,
author = {Hilewitz, D and Trattner, A and Reiter, O and Uvaidov, V and Noyman, Y and Solomon Cohen, E and Hackett, A and Mimouni, D and Snast, I},
title = {Pandemic of sensitivity to acrylate containing nail cosmetic among young Israeli women? Result of patch testing 2‐hydroxyethyl methacrylate in the European baseline series},
journal = {Contact Dermatitis},
year = {2024},
doi = {10.1111/cod.14683}
}
EUVIMED